CoQ₁₀ and Mitochondrial Dysfunction in Alzheimer's Disease

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Alzheimer's disease (AD) pathogenesis involves amyloid beta (Aβ) and tau pathologies, mitochondrial dysfunction, and oxidative stress.
• Early biomarkers and risk factors are key to understanding AD progression.
• Coenzyme Q10 (CoQ10) is vital for mitochondrial electron transport and antioxidant defense.

Purpose of the Study:

• To review the role of CoQ10 in AD pathophysiology.
• To evaluate CoQ10 and its analogues as potential pharmacotherapies for AD.

Main Methods:

• Literature review of AD pathogenesis.
• Analysis of CoQ10's role in mitochondrial function and oxidative stress.
• Evaluation of existing research on CoQ10 in AD models and human studies.

Main Results:

• CoQ10 deficiency is linked to mitochondrial dysfunction observed in AD.
• CoQ10's antioxidant and bioenergetic properties may counteract AD-related cellular damage.
• Pharmacological intervention with CoQ10 could potentially restore mitochondrial function and mitigate Aβ and tau pathologies.

Conclusions:

• CoQ10 holds significant therapeutic potential for Alzheimer's disease.
• Targeting mitochondrial dysfunction and oxidative stress with CoQ10 may offer a novel AD treatment strategy.
• Further clinical studies are warranted to confirm the efficacy of CoQ10 in AD pharmacotherapy.